20/20 Biolabs, Inc. (AIDX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$3.27M

Year ended 2025-12-31

-$4.35M

Trailing 12 months to 2026-06-30

2024-12-31 EBITDA (USD) 2025-12-31

Period ended	EBITDA	Change YoY	Source filing
2025-12-31	-$3.27M	n/m	2026-03-31, From 2025-01-01
2024-12-31	-$5.56M	n/a	2026-03-31, From 2024-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EBITDA	Change YoY
20/20 Biolabs, Inc. (AIDX)	2025-12-31	-$3.27M	n/m
UL Solutions Inc. (ULS)	2025-12-31	$710.00M	+12.0%

Compare AIDX, ULS side by side · Screen every company in Services-Testing Laboratories ↗